Works matching IS 13570560 AND DT 2024 AND VI 41 AND IP 2
Results: 21
Combining lapatinib and palbociclib inhibits cell proliferation and invasion via AKT signaling pathway in endocrine-resistant breast cancer cells.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02290-5
- By:
- Publication type:
- Article
Evaluation of regulatory T-cells in cancer immunotherapy: therapeutic relevance of immune checkpoint inhibition.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02289-y
- By:
- Publication type:
- Article
Modulation of autophagy and apoptosis can contribute to the anticancer effect of Abemaciclib/Celecoxib combination in colon cancer cells.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02288-z
- By:
- Publication type:
- Article
Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage Lymphoma axis-mediated activation of the phosphoinositide 3-kinase/Akt pathway.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02287-0
- By:
- Publication type:
- Article
A novel therapeutic strategy: the significance of exosomal miRNAs in acute myeloid leukemia.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02286-1
- By:
- Publication type:
- Article
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02284-3
- By:
- Publication type:
- Article
Genipin inhibits proliferation of gastric cancer cells by inducing ferroptosis: an integrated study of network pharmacology and bioinformatics study.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02283-4
- By:
- Publication type:
- Article
Chitosan-loaded piperlongumine nanoparticles and kaempferol enhance the anti-cancer action of doxorubicin in targeting of Ehrlich solid adenocarcinoma: in vivo and in silico modeling study.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02282-5
- By:
- Publication type:
- Article
Revolutionizing cancer treatment: comprehensive insights into immunotherapeutic strategies.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02280-7
- By:
- Publication type:
- Article
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02279-0
- By:
- Publication type:
- Article
Role of miRNAs to control the progression of Chronic Myeloid Leukemia by their expression levels.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02278-1
- By:
- Publication type:
- Article
A comprehensive review on the applications of ferrite nanoparticles in the diagnosis and treatment of breast cancer.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02277-2
- By:
- Publication type:
- Article
Nanoemulsion potentiates the anti-cancer activity of Myricetin by effective inhibition of PI3K/AKT/mTOR pathway in triple-negative breast cancer cells.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02274-5
- By:
- Publication type:
- Article
Utility of MRI in detection of PET-CT proven local recurrence of pancreatic adenocarcinoma after surgery.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02271-8
- By:
- Publication type:
- Article
Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02269-2
- By:
- Publication type:
- Article
Arsenic-induced prostate cancer: an enigma.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02266-5
- By:
- Publication type:
- Article
Exploring the role of PRDX4 in the development of uterine corpus endometrial carcinoma.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02265-6
- By:
- Publication type:
- Article
SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02262-9
- By:
- Publication type:
- Article
Histone methyltransferase SUV39H2 regulates apoptosis and chemosensitivity in prostate cancer through AKT/FOXO signaling pathway.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02252-x
- By:
- Publication type:
- Article
Population-based high-dimensional analyses identify multiple intrinsic characters for cancer vaccines against lung squamous cell carcinoma.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02214-3
- By:
- Publication type:
- Article
lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways.
- Published in:
- Medical Oncology, 2024, v. 41, n. 2, p. 1, doi. 10.1007/s12032-023-02263-8
- By:
- Publication type:
- Article